Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-26-025262
Filing Date
2026-01-28
Accepted
2026-01-27 20:45:16
Documents
14

Document Format Files

Seq Description Document Type Size
1 S-3 rkda-20260128.htm S-3 560218
2 EX-5.1 rkda-ex5_1.htm EX-5.1 18189
3 EX-23.1 rkda-ex23_1.htm EX-23.1 3932
4 EX-FILING FEES rkda_exfilingfees.htm   iXBRL EX-FILING FEES 70367
  Complete submission text file 0001193125-26-025262.txt   786924

Data Files

Seq Description Document Type Size
16 EXTRACTED XBRL INSTANCE DOCUMENT rkda_exfilingfees_htm.xml XML 10593
Mailing Address 5956 SHERRY LANE SUITE 2000 DALLAS TX
Business Address 5956 SHERRY LANE SUITE 2000 DALLAS TX 214-974-8921
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-292993 | Film No.: 26567899
SIC: 1311 Crude Petroleum & Natural Gas
(CF Office: 01 Energy & Transportation)